Independent Directors

Dr. Thomas Insel


  • Psychiatrist
  • Neuroscientist
  • National Leader in Mental Health
  • Director of the National Institute of Mental Health (NIMH), the component of the National Institutes of Health (NIH) committed to research on mental disorders, from 2002–2015
  • Co-Director of President Obama’s BRAIN Initiative
  • Led the Mental Health Team at Verily (formerly Google Life Sciences) in South San Francisco, CA. In 2017, co-founded Mindstrong Health, offering virtual care and psychiatric telehealth services for people with serious mental illness.
  • In 2020, co-founded Humanestcare, a global therapeutic online community for recovery.

Dr. Peter Kash


  • 30 Year Wall Street Veteran
  • Co-Founded More Than a Dozen Biotech Firms
  • Six FDA-Approved Drugs Developed by Companies He Co-Founded
  • Significant Experience Raising Private Equity Capital
  • Co-founder and Vice-Chairman of TargImmune Therapeutics
  • Co-founder and former partner of Two River Group
  • Co-founder of PolaRx Biopharmaceuticals; developing the first cancer drug from China, Trienox approved by FDA.
  • Co-founder and former Vice Chairman of Keryx Biopharmaceuticals

Bruce E. Roberts


  • 25+ years of International Banking Experience
  • Expert in Strategic Investment in the Life Sciences, including:
  • Biopharma
  • Consumer-Digital Health
  • Medical Technology
  • Drug-Device Combination Devices
  • Chairman of Nectero Medical
  • Managing Director at RM Global Partners LLC
  • General Partner of the RMGP Bio-Pharma Investment funds: deploying funds into innovative biopharma start-ups in Israel in collaboration with JNJ, Takeda, Bayer and Orbimed
  • Managing Partner of Health Family Capital, LLC
  • National Board of Directors of AdvaMed Accel


Ambassador Ido Aharoni

  • 25-year Veteran of Israel’s Foreign Service
  • Public Diplomat Specialist
  • Distinguished Professor at New York University’s Program of International Relations
  • Member of the International Advisory Council (IAC) of global strategic communications firm DC-based APCO Worldwide
  • Co-Founder and Principal at Israel based consultancy Emerson Rigby Ltd
  • Advisor to Value Base™
  • Chairman of the Charney Forum for New Diplomacy

Dr. Jacob Dagan

  • 35-years of Healthcare Management
  • Deep Experience in Corporate and Product Development, Operations, Marketing and Sales, Hospital Management, Biomedical Development
  • CEO of DaganMD
  • CEO and Founder of Medical Service Options, Inc.
  • Director of Allium Medical, Ltd.
  • Director IBI, Ltd
  • Previously co-founded ProMed Capital LLC

Yair Ephrati

  • 20 Years of Investment Banking and Corporate Finance experience, including M&A Transactions, Divestitures, and Public Equity Transactions
  • Head of Investment Banking of Value Base™
  • CEO and a Director of Value Base™ Mergers & Acquisitions Ltd
  • Founded Y. Ephrati Capital & Management Advisors Ltd., a mid-market investment bank that was later merged into DS Apex Capital
  • Founded Seed2Net, an internet related incubator that focused on founding companies in the telecommunication and internet arenas
  • Chairman and CEO of Eden Energy Discoveries Ltd
  • Board member to multiple organizations: Dan Public Transportation Corporation & Group Companies (2018 – present), Quidie Limited (2017 – present), VBARE Iberian Properties SOCIMI SA (2015 – present), and The Israeli Litigation Funding Fund (2018 – present).

Dr. Jacob Frenkel

  • Chairman, Board of Trustees Group of Thirty, a Private, Nonprofit, Consultative Group on International Economic and Monetary Affairs
  • Former Governor, Bank of Israel
  • Former Chairman, JP Morgan Chase Int’l
  • Former Professor, University of Chicago
  • Chairman, Board of Governors, Tel Aviv University
  • Fellow of the Econometric Society
  • A Foreign Honorary Member of the American Academy of Arts and Sciences
  • A member of the Board of Directors of the National Bureau of Economic Research of the Japan Society and of the Peterson Institute for International Economics.
  • A member of Temasek International Panel (TIP)
  • A member of the International Advisory Council of China Development Bank.
  • A member of the Board of Directors of Boston Properties, Inc.
  • A member of the Board of Directors of the Loews Corporation.

Dr. David Levy

  • Chief Executive Officer at EHE Health
  • An accomplished physician executive with a record of achievement in founding, leading, and/or turning around a variety of health care services companies
  • Serves on the boards of leading: Medical device, Technology, and Services companies in the US, Israel, and Brazil
  • Founded Franklin Health Inc., (now owned by Optum)
  • Previously a Partner at PwC leading Global Healthcare business

Dr. Steven Miller

  • Executive Vice President & Chief Clinical Officer Cigna Corporation
  • A nationally recognized advocate for greater access, affordability and excellence in healthcare, leads all the Cigna’s clinical policy, quality and performance efforts
  • Chief Medical Officer and Senior Vice President Express Scripts
  • Improved health outcomes and value through e-prescribing, specialty solutions and overall product development.
  • Chief Medical officer and Vice President at Barnes-Jewish Hospital, Washington University.

Edward Neugeboren

  • 27 years experience in pharmaceutical operations, investment banking, business development, portfolio management, corporate management and institutional equity research
  • Chief Strategy Officer of a pharmaceutical group comprised of Rising Pharma Holdings, Inc., a top US generic pharmaceutical company, Cronus Pharma, LLC, a leading animal health pharmaceutical company, Casper Pharma, LLC, a specialty pharmaceutical company and Grace Therapeutics, Inc., a rare and orphan central nervous pharmaceutical company.
  • Founder and Managing Partner of QuadView Healthcare Advisors, previously named ArcLight Advisors, LLC, a healthcare investment banking and business development firm.
  • Managing Director of Ledgemont Capital Group, LLC, an investment banking firm providing strategic and financial advisory services to growth companies with a specialty in Healthcare
  • Managing Partner of Third Ridge Capital Management, LLC, a long/short U.S. equity hedge fund.
  • Chief Administrative Officer and Director of Equity Research Operations at Lehman Brothers
  • Managed the equity research business of Lehman’s strategic alliance with Fidelity Investments.
  • Deputy Director of Equity Research at UBS, formerly Warburg Dillon Read
  • Equity research analyst covering the Specialty Pharmaceuticals industry, including Generic Drugs and Drug Delivery at Dillon, Read & Co., Kidder, Peabody & Co., and Furman, Selz, Inc